Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism Bcr-Abl inhibitors(Bcr-Abl tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Shenzhen TargetRx, Inc.Startup |
Active Organization Shenzhen TargetRx, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic phase chronic myeloid leukemia | Preclinical | CN | Shenzhen TargetRx, Inc.Startup | 07 Dec 2024 |